Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke

Monteiro, Jean M C; San-Martin, Daniel L; Silva, Beatriz C G; Jesus, Pedro A P de; Oliveira Filho, Jamary.
Arq. neuropsiquiatr ; 76(1): 22-25, Jan. 2018. tab
Artigo em Inglês | LILACS | ID: biblio-888342

Similares

  1. Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke.
  2. Transplantation for chagas' disease: closing the knowledge gap.
  3. Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
  4. Sequential measurement of Trypanosoma cruzi parasitic load in endomyocardial biopsies for early detection and follow-up of Chagas disease reactivation after heart transplantation.
  5. Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants.
  6. Winding Down the Storm: Could Empagliflozin's Ion-Dependent Mechanisms Tackle the Ventricular Arrhythmia Burden in Chronic Chagas Cardiomyopathy?
  7. Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention.
  8. Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon.
  9. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.
  10. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.